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During the course of evolution, multicellular organisms have been orchestrated with an
efﬁcient and versatile immune system to counteract diverse group of pathogenic orga-
nisms. Pathogen recognition is considered as the most critical step behind eliciting adequate
immune response during an infection. Hitherto Toll-like receptors (TLRs), especially the
surface ones viz. TLR2 and TLR4 have gained immense importance due to their extreme
ability of identifying distinct molecular patterns from invading pathogens. These pattern
recognition receptors (PRRs) not only act as innate sensor but also shape and bridge innate
and  adaptive immune responses. In addition, they also play a pivotal role in regulating
the  balance between Th1 and Th2 type of response essential for the survivability of the
host. In this work, major achievements rather ﬁndings made on the typical signalling and
immunopathological attributes of TLR2 and TLR4 mediated host response against the major
infectious diseases have been reviewed. Infectious diseases like tuberculosis, trypanosomia-
sis, malaria, and ﬁlariasis are still posing myriad threat to mankind. Furthermore, increasing
resistance of the causative organisms against available therapeutics is also an emergingproblem. Thus, stimulation of host immune response with TLR2 and TLR4 agonist can be
the  option of choice to treat such diseases in future.
© 2016 Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC
and intracellular (TLR3, TLR7, TLR8, and TLR9). These evo-B
ntroduction
ntimicrobial inﬂammatory response primarily onsets
hrough initial sensing of distinct pathogen associated
olecular patterns (PAMPs) by pattern recognition receptors
PRRs) of hosts. These receptors serve as crucial innate PRRs
hat sense microbial or endogenous products released from
amaged or dying cells and trigger innate immunity through
he activation of intracellular signal transduction pathways.1
∗ Corresponding author.
E-mail address: spsinhababu@gmail.com (S.P.S. Babu).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.bjid.2015.10.011
413-8670/© 2016 Published by Elsevier Editora Ltda. This is an 
reativecommons.org/licenses/by-nc-nd/4.0/).-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Amongst the innate immune PRRs, Toll-like receptors (TLRs)
have the unique capacity to sense the initial infection and are
the most potent inducers of the inﬂammatory responses.1
Depending on their cellular localization or respective PAMPs
they identify, TLRs can be divided into two sub groups such
as transmembrane (TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11)
1lutionary conserved type-I transmembrane proteins (TLRs)
can recognize ligand from almost all types of pathogenic
organisms including viruses, bacteria, fungi, protozoa,
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helminths, etc. Structurally, TLRs located on cell membranes
possesses an extracellular domain containing leucine-rich
repeats that recognize distinct PAMPs and a toll-interleukin
1 (IL-1) receptor (TIR) domain required for downstream
signalling that guides activation of transcription factor
nuclear factor-B (NF-B) for inducing pro-inﬂammatory
cytokines and chemokines as well as the up-regulation of
co-stimulatory molecules on antigen presenting cells, such
as macrophages (Ms) and dendritic cells (DCs) that in turn
sensitize T-cell activation. Inﬂammation signalled from TLR
is a protective measure of the host body to ensure removal
of detrimental threats posed by infectious agents as well as
to accelerate the healing process. However, the Th1 biased
inﬂammatory consequences orchestrated by TLRs not only
involve in eliminating pathogenic infections but also can
induce fatal pathological outcomes like septic shock (Fig. 1).
Similarly, pathogen modulated TLR signalling develops a
Th2 based response beneﬁcial for the pathogen i.e. disease
progression (Fig. 1). Thus, an adequate balance between pro-
and anti-inﬂammatory immune responses is of immense
importance to restore the normal physiological conditions
of the host body during and after a pathogenic infection.2
Herein, major research ﬁndings exploring the role of TLR2 and
TLR4 in the induction of host immunity against major par-
asitic diseases such as tuberculosis, leishmaniasis, malaria,
trypanosomiasis, and ﬁlariasis have been reviewed.
Immunobiology  of  TLR2  and  4Since their discovery, TLR2 and 4 have gained much atten-
tion due to their extreme ability of identifying diversiﬁed array
of pathogenic ligands.1 Alike Drosophila protein ‘Toll’, mam-
malian TLR2/4 possesses a cytosolic IL-1 receptor homologi-inﬂammatory (Th2) polarization of immune cells.
domain but heterologous extracellular leucine-rich repeats.3
Interestingly, the mode of signalling is highly similar for
e.g. transcription factor ‘Dorsal’ activated by Toll pathway in
Drosophila is a functional homologue of NF-B.4 The mode of
activation of NF-B or Dorsal also share high degree of simi-
larity in terms of signalling intermediates like protein kinases
such as ‘Pelle’ of Drosophila5,6 and mammalian IL-1 receptor-
associated kinase.7 A comparative homology in the signal
pathway transduced by Drosophila ‘Toll’ and mammalian “TLR”
have been depicted in Fig. 2.
The functional features of “Toll signaling” are primarily dif-
ferent from insect to mammals. As obvious, ‘Toll’ receptors
in insect (Drosophila) perform developmental roles primarily
but it serves as innate immune receptor majorly in mammals.
The proteins involved in the dorso-ventral polarity also play
crucial role in the antimicrobial response in the ﬂy as well.8
Interestingly, intermediates of dorso-ventral polarity deter-
mining ‘Toll’ pathway of insect share high degree of homology
with vertebrate TLRs (speciﬁcally TLR4) that performs pattern
recognition.8 Thus, the functional ancestry between develop-
ment and immune pathway has been emerged as a major
question. In particular, the discovery of immune function of
‘Toll’ in Drosophila also suggested towards the fact that the
immune function of the Toll gene product was not adapted
by the higher animals rather it can be revealed that the
coordination and integration and/or cross talk between the
intermediates of ‘Toll signaling’ has been improved with the
increase in complexity among animals most likely during the
course of evolution.8 In addition, unrelenting selective pres-
sure exerted by the rapidly evolving pathogenic organism also
8contributed in this adaptive evolution of ‘Toll’ receptor. Partic-
ularly for TLR4, evolution of the gene (mostly due to mutation)
led to differential expression of TLR4 with different afﬁnity
and speciﬁcity to its PAMP8 which may be the reason behind
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esistance/susceptibility to an infectious disease. However, the
xact molecular explanation of the mechanism involved in
he introduction of immune functioning in the “Toll pathway”
longside its developmental function or its functional diver-
ence still remains as a shaded area in our understanding.
Being among the cell surface TLRs, TLR2 and 4 shape
athogen speciﬁc innate immunity through distinct ligand
inding which in turn develops antigen-speciﬁc acquired
mmunity as well. These two TLRs are the best characterized
RRs which not only identify invading pathogens outside the
ell but also intracellular pathogens captured in endosomes
r lysosomes.9 TLR2 and 4 can sense PAMPs from various
nfectious micro and macro organisms as summarized in
able 1. The best possible explanation of cell surface TLR
ctivation is the presentation and binding of lipopolysac-
haride (LPS) to TLR4. Under pathogenic condition, a soluble
lasma protein namely LPS-binding protein (LBP) interacts
nd binds with LPS.9 The entire LPS-LBP complex handed over
o glycosyl phosphatidyl inositol linked CD14 ﬁrstly and then
n to the TLR4-MD2 complex.9 TLR4 forms a complex with
D2  on the cell surface which serves as the main LPS-bindingcomponent.1 Five out of the six lipid chains of LPS occupy
the hydrophobic pocket of MD2 and the remaining lipid chain
exposed to the surface on MD2 associates with TLR4.1 The
phosphate groups on sugar moieties also interact with the
positively charged residues of TLR4. The multimeric receptor
composed of two copies of the TLR4-MD2-LPS complex result-
ing initiation of signal transduction by recruiting intracellular
adaptor molecules such as Myeloid differentiation factor
88 (MyD88), TIR-related adaptor protein inducing interferon
(TRIF), TRIF-related adaptor molecule (TRAM), TIR domain
containing adaptor protein (TIRAP) or MyD88 adaptor like
(MAL), and Sterile-alpha and Armadillo motif-containing
protein (SARM). The summary of mode of ligand recognition
by TLR4 has been depicted in Fig. 3.
TLR2 forms an m-shaped heterodimers with either TLR1
or TLR6 for recognizing tri- or di-acylated lipopeptides
respectively from the pathogens (Gram-negative bacteria,
mycoplasma, etc.).3 Out of the three lipid chains of tri-acylated
ligand (lipopeptide e.g. Pam3CSK4), two interact with TLR2 in
the TLR2-TLR1 heterodimer whereas the third chain occupies
the hydrophobic channel of TLR1.7 An absence of hydrophobic
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Table 1 – Recognition of ligand and functional immunobiology of different TLRs against array of pathogens.
Organism Ligand(s) Targeted
receptor
Localization of ligands Effector function
Bacteria
Gram-negative bacteria Lipopolysaccharide (LPS) TLR4 Outer membrane Induces proinﬂammatory
response10
Gram-positive bacteria Peptidoglycans TLR2 Cell wall Enhances inﬂammatory
response10
Streptococcus B Lipoteichoic acid TLR2 Protoplast membranes Initiates inﬂammatory
response10
Staphylococcus aureus Phenol soluble modulin(PMS) TLR2 Extracellular Inhibit proinﬂammatory
cytokines TNF, IL-12 and IL-611
Trepanema maltophilum Glycolipids TLR2 Outer membrane surface Including the
pro-inﬂammatory cytokines
interleukin (IL)-1, IL-6, and
tumour necrosis factor
(TNF)-12
Wolbachia Wolbachia surface protein (WSP) TLR2 Membrane surface Induces TNF-, IL-12, and IL-813
Wolbachia Wolbachial liporotein TLR2 Bacterial membranes Induces TNF- production and
up-regulates surface markers
of human lymphatic
endothelium13
Borrelia burgdorferi Outer surface protein A
lipoprotein (OspAL)
TLR2 Outer membrane surface Induces the inﬂammatory
response & down-regulate the
cell response to ﬂagellin14,15
Staphylococcus epidermidis PSM TLR2 Bacterial cell surface Induce cytokine release16
Mycobacterium tuberculosis 19 kDa lipoprotein TLR2 Cell wall Induces apoptosis and inhibits
IFN- induced expression of
several immune function
genes17
Pseudomonas aeruginosa LPS  TLR4, TLR2 Outer membrane Induces TNF- and IL-618
Pseudomonas aeruginosa Lipoprotein (OprI) TLR2, TLR4 Outer membrane Modulate allergen-speciﬁc Th2
effector cells19
Virus
Measles Hemagglutinin (HA) TLR2 Cytoplasm Suppresses IL-12 production20
Herpes Herpes Simplex Virus (HSV) TLR2 Golgi complex TNF-and the IFN-stimulated
gene CXCL921
Respiratory syncytial
virus (RSV)
F  protein TLR4 Membrane of the
endoplasmic reticulum (ER)
Inﬂammatory cytokines
(TNF-, IL-6, etc.), type-1
interferons22
Mouse mammary tumour
virus (MMTV)
Envelope protein TLR4 Nucleolus Inﬂammatory cytokines
(TNF-, IL-6, etc.), type-1
interferons22
Fungi
Saccharomyces cerevisiae Zymosan TLR2 Cell wall Inﬂammatory cytokines
(TNF-, IL-6, etc.), type-1
interferons22
Saccharomyces cerevisiae Mannan TLR4 Cell wall Triggers TNF- production23
Candida albicans Mannan TLR4 Cell wall Induces secrction of tumour
necrosis factor(TNF)-23
Candida albicans Phospholipomannan TLR2 Cell wall Stimulate tumour necrosis
factor (TNF)- production24
Cryptococcus neoformans Glucuronoxylomannan (GXM) TLR4 Capsule Up-regulation of FasL25
Aspergillus fumigatus Galactomannan TLR4 Hyphae/Mycelium Downregulates the IL-6 and
TNF- production26
Protozoa
Trypanosoma cruzi GPI anchor TLR2 Outer leaﬂet of the lipid
bilayer
Proinﬂammatory cytokine
release, interleukin12 (IL-12),
nitric oxide (NO) and tumour
necrosis factor (TNF)
production27 Cytokine
induction
Trypanosoma cruzi Glycoinositolphospholipids TLR4 Outer leaﬂet of the
membrane
Induces IL12, TNF-˛, and nitric
oxide (NO) production28
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Table 1 – (Continued)
Organism Ligand(s) Targeted
receptor
Localization of ligands Effector function
Plasmodium falciprum GPI  anchor TLR2, TLR4 Cell membrane Induces TNF-and reduced
IL-10 production29
Toxoplasma gondii GPI anchors TLR2, TLR4 Microneme Induces TNF- production22
Leishmania donovani Galbetal 1,
4Manalpha-po(4)-containing
phosphoglycans
TLR2 Surface Induces nitric oxide (NO) and
proinﬂammatory Cytokines30
Leishmania major Lipophosphoglycan (LPG) TLR2, TLR4 Entire surface of the
parasite
Induces IL-12, TNF-, IFN-,  NO
production31
Leishmania major Ecotin-like serine peptidase
inhibitor
TLR2, TLR4 Cytosol Up-regulation of
proinﬂammatory cytokines31
Leishmana sp. SHP-1 TLR2 Nuclear envelope Inhibition of pro inﬂammatory
gene expression32
Leishmania mexicana SHP-1 TLR2 Nuclear envelope Block IFN-mediated nitric
oxide (NO) production in
macrophages33
Entamoeba histolytica Lipopeptidophosphoglycans
(LPPG)
TLR2,  TLR4 Cell surface of the
trophozoites
Leads to TNF-,  IL-12, IL-10,
and nitric oxide release in
phagocytes34
Nematode
Filarial nematode Lacto-N-fucopentaose III
(LNFPIII)
TLR4 Surface Promote type 2 responses35
Acanthocheilonema Viteae Phosphatidyl Choline moiety
(ES-62)
TLR4 Surface Blockade of IL-12 and TNF-
Production36
Ascaris lumbricoides phospholipids TLR2 Muscle, cuticle Induces Th2 response37
Trematode
Schistosoma mansoni Lysophosphatidylserine
(lyso-PS)
TLR2  Tegumental surface
membrane
Induce the development of
IL-10-producing regulatory T
cells38
Schistosoma mansoni Glycolipid (LFNPIII) TLR2 Surface membrane Induction of Treg& IL-1035
Schistosoma mansoni Schistosoma soluble egg
antigen (SEA)
TLR2  Egg and adult tegument Up-regulation of OX40L in DC
and block the Th2 response35
Schistosoma mansoni Lysophosphatidylserine [LPhS
(SWA)]
TLR2 Surface membrane Generation of IL-10-producing
Treg cells35
Schistosoma japonicum HSP60 (SjHSP60)-derived
peptide SJMHE1
TLR2  Surface membrane InducesTreg with
immunosuppressive activity39
Cestode
Taenia crassiceps Taeniacrassiceps
excreted/secreted antigens
(TcES)
TLR4 Excretory or secretory
products
Impaired pro-inﬂammatory
cytokine production and
increased Th2 biasing ability of
dendritic cells40
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hannel in TLR6, TLR2-TLR6 heterodimer cannot recognize
riacylated lipopeptides. Other than discrimination between
ipoproteins, TLR2 has the ability to act together with co-
eceptor (CD36) by working with the heterodimer to mediate
he sensing of some but not all TLR2 agonists which induces
nternalization.42 Thus TLR2 is involved in the recognition of
 wide range of PAMPs derived from bacteria, fungi, parasites
nd viruses also. TLR2, together with its co-receptors, TLR1
nd TLR6, requires internalization to trigger NF-B activation
n response to Lipoteichoic acid (LTA) and Pam3CSK4 that pro-
ides a novel accepting mechanism on how TLRs coordinate
igand recognition and subsequent triggering of a speciﬁc
ignal.43 Despite the expression of TLR2 at the cell surface, the
acterial TLR2 ligands namely Pam3CSK4 and LTA can induce
F-B-dependent signalling from endosomal compartments
eported for human monocytes and for a NF-B sensitive
eporter cell line.43Membrane surface Diminish the production of
proinﬂammatory cytokines41
TLR2 and 4 are expressed in various immune cells includ-
ing neutrophils, monocytes/Ms and DCs.44 Amongst these,
neutrophils ﬁrst migrate to the site of infection, sense the
pathogen and elicit immune response. However, coordinated
activation of adaptive response is mediated through binding
of speciﬁc ligand to monocytes or DCs that are also medi-
ated principally by TLR2 and 4.45 Moreover, these TLRs are
also expressed on classical adaptive immune cells viz. B and
T lymphocytes.46
After recognizing PAMPs by the TLR2 and 4 in a particu-
lar cell type, cytosolic TIR domain and associated adaptors
(MyD88, TRIF, and SARM) are activated that in turn drive acti-
vation of the transcription factors such as NF-B and/or IRF3.
Activation of these TLRs triggers two distinct signalling path-
ways viz. MyD88 dependent and MyD88 independent or TRIF
dependent pathway. MyD88, TRIF, TRAM, MAL, and SARM are
the ﬁve important adaptors of TLR activation. MyD88 is the
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ﬁrst amongst the adaptors used by all TLRs except TLR3. Upon
TLR activation, MyD88 recruits interleukin 1 receptor asso-
ciated kinase 4 (IRAK-4) that phosphorylates IRAK1 which
in turn activate TNF Receptor-Associated Factor 6 (TRAF6).
Both proteins leave the receptor complex and interact with
TGF--activated kinase 1 (TAK1) and two TAK1 binding pro-
teins TAB1 and TAB2. TAK1 becomes phosphorylated and
activates the I-B kinase (IKK) complex comprising IKK,
IKK, and NEMO/IKK,  and Mitogen-activated protein kinase
(MAPK) leading to the activation of NF-B and c-Jun N-terminal
kinases (JNK) signalling pathways respectively for triggering
the expression of cytokines (IL-6, IL-12, TNF-).47 I-B is then
phosphorylated allowing NF-B translocation to the nucleus
and induces expression of pro-inﬂammatory cytokines. TAK1
is also capable of phosphorylating MKK6 and 7 which leads
to the activation of p38 and JNK. MAL  or TIRAP is the second
adaptor that transmits signal from TLR4 and TLR2 by facili-
tating movement  of MyD88 to TLR4 and/or possibly to TLR2
for transcription factor activation like NF-B, JNK and Extra-
cellular regulated kinases 1(ERK-1).48 TRIF is the third adaptor
for TLR4 and TLR3 that activates Interferon regulatory factor
3 (IRF3) by activating the kinases TBK1 and the I-B kinase D .
Fourth adaptor is TRAM which is one of the interacting part-
ners of TRIF. TRAM involves in transmitting TLR4 signalling
and results in MyD88-independent interferon- production.49
The ﬁfth adaptor is SARM which mainly interact with TRIF and
negatively regulate NF-B and IRF3 activation.50
Activation of IRF3 and NF-B are the principal targets
of TRIF-dependent pathway.51 TRIF recruits TRAF6 and
activates TAK1 for NF-B activation through ubiquitina-
tion dependent mechanisms similar to those of the MyD88
45dependent pathway. TRIF forms a multiprotein signalling
complex along with TRAF6, TNFR-associated death domain
(TRADD), Pellino-1 and Receptor-interacting protein1 (RIP1)
required for the activation of TAK1, which further activatested actions of serum LBP, membrane bound CD14 and MD2.
NF-B and MAPK.1 In addition to NF-B activation, the
TRIF-dependent pathway also leads to IRF3 activation and
interferon- transcription.52 TRIF recruits another signalling
complex involving the non-canonical IKKs, TBK1 and IKKi
(IKK), which catalyze the phosphorylation of IRF3 and induce
nuclear translocation to mediate transcription of target
genes.53 TRAF3 is also incorporated into the MyD88 complex
during signalling. Degradation of TRAF3 results in the translo-
cation of the membrane proximal signalling complex to the
cytoplasm leading to TAK1 activation that phosphorylates the
IKK complex to mediate NF-B activation.54 The mechanism
of signalling induced from TLR-ligand interface to mediate
inﬂammatory response has been presented in Fig. 4.
Involvement  of  TLR2  and  TLR4  in  infectious
diseases
Diseases caused by parasites/microbes are just not the burden
for mankind; they are economically considered as biohazards.
Major infectious diseases like tuberculosis (TB), malaria, leish-
maniasis, trypanosomiasis, and ﬁlariasis are the deadliest for
the extent of harm they result. In this section, current sce-
nario of the diseases of our interests has been presented with
up-to-date information.
Tuberculosis
Tuberculosis (TB) caused by the intracellular bacterium
Mycobacterium tuberculosis, capable of surviving within host
mononuclear cells, remains one of the world’s deadliest
communicable diseases. TB is a major public health prob-
lem causing 10 million new infected cases diagnosed each
year whereas deaths of 2 million victims.55 In 2013, an esti-
mated 9.0 million people developed TB and 1.5 million died
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rom the disease worldwide (WHO, 2014). TLR2 and 4 sig-
iﬁcantly contribute in the typical immune response in TB
nd their interaction with Mycobacterium tuberculosis believed
o be the principal event. The decision behind progression
r elimination depends what type of microbacterial ligand
inds to these receptors.56 In general, mycobacteria have
dopted sophisticated evasion strategy to bypass Ms through
lternative activation whereas elimination of mycobacterial
nfection is predominantly occurring by classically activated
s.57 Kusner58 has reported a 19 kDa mycobacterial sec-
etary lipoprotein that activates murine and human Ms
o secrete TNF- and nitric oxide (NO) via interaction with
LR2, but not TLR4. Mycobacterial glycolipids like lipoara-
inomannan (LAM), lipomannans (LM), phosphatidylinositol
annosides (PIM2, PIM6), and a 19-kDa lipoprotein, are the
ycobacterial PAMPs believed to cause M activation via the
LR2 activating innate pathway by regulating tumour necro-
is factor (TNF-) and IL-10 secretion reported for human
onocyte-derived Ms.57 The interaction of Ms with M.
uberculosis through TLRs is critical in deﬁning the cytokine
roﬁle that may or may not control disease progression. This
nteraction promotes the synthesis of antibacterial molecules
e.g., NO) and several cytokines, including TNF-, interleukin-
 (IL-6), IL-1, and IL-12.57 In DCs, the engagement of TLR2
ith these PAMPs induces the secretion of anti-inﬂammatory response to speciﬁc ligand from pathogen.
cytokines such as IL-10, a cytokine that promotes disease
progression, by mechanisms that limit the inﬂammatory
response.57 Along with cytokine expression TLR2 activation
leads to NO dependent and independent killing of intracellular
M.  tuberculosis in mouse and human Ms respectively.59 Apo-
ptosis by infected host cells is also mediated by TLR2 mediated
pathway involving MyD88, Fas-Associated protein with Death
Domain (FADD) and caspase-8 in which MyD88 associates with
FADD via their respective death domains.60 A scheme on TB
induced TLR activation has been shown in Fig. 5.
Malaria
Malaria is a mosquito borne infectious disease of humans and
other animals caused by parasitic protozoan of genus Plasmo-
dium (WHO, 2014) causing huge number of death each year.61
The host response during malaria infection, expresses high
levels of many  proinﬂammatory cytokines, including TNF-,
IL-1, IL-6, IL-12 and IFN- that have important roles in control-
ling parasite growth.62 Such types of responses are primarily
originated from interaction of malarial surface molecules and
TLRs of host immune cells. Till date, search for TLR activating
PAMPs from malarial parasites have been the major high-
lighted objective for last few decades. In this connection, a
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Fig. 5 – Recognition of ligand and onset of inﬂammatory response against bacteria, protozoan and nematode parasites.glycolipid moiety, glycosyl phosphatidyl inositol (GPI) from P.
falciparum has been reported to be a ligand of both TLR2 (het-
erodimeric form with TLR1 and TLR6) and TLR4.63 Malarial
GPI is structurally dissimilar than human and comprises a
conserved ethanolamine phosphate-substituted oligosaccha-
ride moiety, EtN-P-6Mana1-2Mana1-6Mana1-4GlcN, linked to
phosphatidylinositol by a (1-6)-glycosidic bond.29 The cova-
lently linked fatty-acyl moieties of GPIs display a speciﬁc
pattern for recognition by TLR2 and the co-receptors. This
malarial ligand from infected erythrocytes interact with the
mentioned TLRs located on Ms or DCs and contribute to the
immunopathology of the infection by inducing the expres-
sion of proinﬂammatory cytokines, such as TNF-, IL-6 and
IL-1. In addition, GPI anchored proteins, merozoite surface
protein 1 (MSP1) and MSP2, two major asexual blood stage
surface antigens, have endotoxin activity that indeed results
in decreasing frequency of the parasitic load from host.63
Moreover, such immunostimulatory host response by these
surface proteins are induced through their binding to TLR4
and activation of immune signalling leading to release of
cytokines from Ms or DCs. P. falciparum GPI-induced M acti-
vation is typically CD36 dependent transmits through MAPK,
namely extracellular signal regulated kinase (ERK), p38 and
c-Jun N-terminal kinase (JNK) pathways as well as through
the Nuclear factor- kappa B (NF-B).29 In addition, studies
using inhibitors of p38 activity and ERK1/2 activation indicated
towards signiﬁcant crosstalk among the GPI activated MAPKpathways represents redundant and overlapping functions in
the initiation and regulation of innate immune responses.29
Activation of TLR4/MyD88 dependent signalling pathway
during the malarial infection results in the excessive proin-
ﬂammatory cytokine production responsible for the several
symptoms of the diseases.29 This adaptor protein plays a more
prominent role in pathogenesis, rather than in protection. A
scheme on malaria induced TLR activation has been shown in
Fig. 5.
In particular, reactive oxygen and nitrogen radicals pro-
duced by the malaria sensitized Ms guides immune system
by TNF-, IL-12, and IFN- to kill these parasites through the
induction of apoptosis.29 These proinﬂammatory cytokines
facilitate parasite-speciﬁc adaptive immunity for efﬁcient par-
asite clearance to sustained and effective protection against
disease pathology. However, overwhelmed proinﬂammatory
response often results in fatal outcomes.29 On other side, cell-
mediated adaptive immune responses and the modulation
of humoral responses by the induction of antibody isotype
switching occur mainly by the involvement of IL-12.29 Gener-
ally, a gradual down-regulation of proinﬂammatory cytokine
production occurs with a parallel increase in the expression
of anti-inﬂammatory cytokines (IL-10) when the parasite bur-
29den starts declining during malaria infection. However this
balance is required for ﬁghting against the infection while
escaping pathogenesis might not always be reached, con-
tributing to medical situations.
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eishmaniasis
eishmaniasis is caused by a protozoa parasite and transmit-
ed to humans by the bite of infected female phlebotomus
andﬂies. This disease is the second-largest parasitic killer
n the world (after malaria), responsible for an estimated
00,000–400,000 infections each year worldwide (WHO, 2015).
he anti-leishmanial host response typically depends on the
uality of the adaptive immune response primarily induced
rom host-parasite interaction. Especially, interaction between
eishmanial parasite and innate immune receptors rather
LRs results generation of inﬂammatory mediators to deprive
arasite burden and develops efﬁcient adaptive responses.
ipophosphoglycan (LPG), the major identiﬁed ligand from
hese parasites, has been reported to induce inﬂammation
hrough TLR2 and 4.64,65 LPG occurs both in the parasite sur-
ace as well as in the secretory form and these two forms
re structurally similar but differ in the average number of
hosphorylated oligosaccharide repeat units present and in
he sugar types present in the glycan. Up-regulation and acti-
ation of TLR2 on human Natural killer (NK) cells by LPG of
. major results enhancement of TNF- and IFN-. However,
nteraction of LPGs with the TLRs is also inﬂuenced by the
tructural diversity of the phosphoglycan. Likewise, LPG of L.
ajor, L. mexicana, L. aethiopica,  and L. tropica were reported as
lassical TLR2 ligand of Ms whereas performance of L. trop-
ca LPG is not so much satisfactory.65 Study on the induction of
NF- in M  by L. major LPG showed need of a lipid anchor and
 functional MyD88 adaptor.65 Such MyD88-dependent path-
ays are particularly important in developing protective IL-12-
ediated Th1 response against the parasite.65 The L. infantum
rotein related to the silent information regulator 2 (SIR2)
amily has been reported for stimulating the proliferation of
ctivated B lymphocytes, overexpression of major histocom-
atibility complex- (MHC) II and the co-stimulatory molecules
D40 and CD86 as well as maturation of DCs accompanied
y the secretion of IL-12 and TNF- are principally governed
hrough TLR2.64 In spite of its proinﬂammatory activity, LPG
as been shown to inhibit the progression of inﬂammatory sig-
alling originated from TLR2/TLR4 by inducing the expression
f suppressors of the cytokine signalling (SOCS) family pro-
eins viz. SOCS-1 and SOCS-3.65,66 Another exciting fact about
PG is that production of ROS is induced through the interac-
ion between membrane LPG and immune cell TLR-2 leading
o the differentiation of Th2 subsets whereas Th1-promoting
ytokines are reported to be induced solely by soluble LPG.65
PG potentiated inﬂammatory responses through TLR2 stimu-
ation and IL-12 expression followed by Th1 responses in mice
as also reported after treating with synthetic oligosaccharide
nalogues of LPG glycan structure indicating the importance
f glycan in the immunostimulatory activity of LPG.65 Interest-
ngly, parasites also use the same ligand as well as the TLRs to
upress the immune cell activation required for parasites’ ben-
ﬁt i.e. disease progression. Faria et al.65 reported L. donovani
nfected human THP1-derived Ms showed suppression in the
LR2 stimulated IL-12 release with increased production of IL-
0 resulted from the inhibition of MAPKp38 phosphorylation
nd activating ERK1/2 phosphorylation. In addition, L. dono-
ani, L. mexicana, and L. major have been reported to exploit6;2 0(2):193–204 201
the M  tyrosine phosphatase SHP-1 to inactivate kinases
(e.g. IRAK) involved in TLR signalling.32 A graphical summary
on leishmanial parasite induced TLR activation is shown in
Fig. 5.
Proteoglycolipid complex (P8) composed of acysteine and
serine metalloprotease, host-derived Apolipoprotein E (ApoE),
and four glycolipids has been reported as another potential
TLR4 ligand of Leishmania detected in L. pifanoi amastig-
otes that inﬂuence phagocytosis through TLR activation.65
Activated TLR4 at the parasitophorous vacuole affects the
microenvironment surrounding the parasite for its control.
Particularly for the neutrophils, TLR4 induces IRAK4 for exo-
cytosis of neutrophil secretory granules.65 Mechanistically,
P8 sensitized Ms induce proinﬂammatory cytokines viz. IL-
1 and TNF- through TLR4, MD2, CD14, and MyD88.65 In
addition, metacyclic promastigotes have been reported to
induce phosphorylation of the MAP  kinases such as ERK,
p38, and JNK through TLR4 in L. mexicana.67 During such
course of inﬂammation of M, iNOS, Cyclooxygenase-2 (COX-
2), Prostaglandin E2 (PGE2), NO and arginase-1 are been the
mediators.67
Trypanosomiasis  (Chagas  disease)
Chagas disease or American trypanosomiasis, is a tropical par-
asitic disease caused by the protozoan Trypanosoma cruzi (CDC,
2015) and transmitted by insects vector like Triatominae or
kissing bugs. In Latin America it causes a health threat for an
estimated 10 million people and more  than 25 million people
are at risk. Typical immunity against Chagas disease is princi-
pally mediated by innate recognition through TLRs. Although
studied less, TLRs have been characterized as crucial determi-
nants in evoking anti- T. cruzi immune response in which both
TLR2 and TLR4 are the key mediators.68 In particular, these
receptors mediate internalization of trypanosomatid through
phagocytosis required for initiating the immune response by
phagosomal maturation to kill the parasite followed by anti-
gen presentation.69 Researchers have demonstrated fusion of
early endosomes, and phagocytosis induced by trypomastigo-
tes in Ms by ligation of guanine phosphonucleotide- binding
proteins Ras-related protein- (Rab-) 5 solely through TLR2.69
TLR2 activation has been reported to proceed via MyD88-
dependent pathway.69 Secretion of chemokines signalled from
TLR2 activation further recruit leukocytes to control the infec-
tion in a broad way.28 In particular, TLR2 signalling is targeted
by the trypanosomatids to hinder the immune response
induced by the parasite.
However, TLR activation resulted from immune cells-T.
cruzi interaction may also contribute to the disease pathology
as well.69 Involvement of TLR activation in the immunopathol-
ogy of chronic Chagas’ cardiopathy has been reported to be
due to a single-nucleotide polymorphism in the genes cod-
ing for the signalling proteins of TLR signalling and leads to
differential susceptibility to Chagas disease.69 For example,
T. cruzi-infected individuals have heterozygous MAL/TIRAP
S180L variant shows poorer signal transduction after binding
of the trypanosomal ligand to TLR2 or TLR4 resulting in lesser
chance of developing chronic Chagas’ cardiomyopathy.69 A
i s . 2 0
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summary on trypanosomatid induced TLR activation has been
shown in Fig. 5.
Filariasis
Lymphatic ﬁlariasis, a vector borne neglected tropical dis-
ease, mainly caused by three species of nematode parasites-
Wuchereria bancrofti, Brugia malayi, and B. timori is considered
to be a major public health burden (WHO, 2015). Pathological
manifestations of this disease mainly include lymphedema,
elephantiasis and rarely a greater degree of neurological
manifestation.70 Recent studies also showed existence of co-
infection of ﬁlarial parasite with bacteria (TB),49 malaria 49,71
and opportunistic yeast.72 In general, the immunoresponse
in ﬁlariasis is complicated and unresolved especially the
involvement and functional role played by TLR2 and TLR4.49
Filarial intracellular symbiotic bacterium, Wolbachia has been
reported to cause inﬂammation through its lipopolysaccha-
ride (of outer membrane) after binding with TLR4. TLR2 and
TLR4 are also capable to bind other Wolbachial products like
Wolbachia surface protein (WSP) and induce inﬂammatory
response by secreting pro-inﬂammatory cytokines from Ms
and DCs.13 Such proinﬂammatory responses are of immense
importance to eliminate the infection from host. However,
ﬁlarial nematodes also target TLR2 and TLR4, especially TLR4,
for modulating host immune response. A phosphorylcholine-
conjugated glycoprotein molecule namely ES-62 binds TLR4
and create anti-inﬂammatory/Th2 biased immune response
to prolong survivability of the parasite inside host.36 In chronic
infection, ﬁlarial nematode induces apoptotic death of T
cells for down  regulating host response and interestingly
the process is also operative through TLR4.73 Live micro-
ﬁlarae of B. malayi have been reported to modulate TLR4
expression in monocyte derived human DCs (mhDCs) to
induce an immunosuppressive environment in host through
interference of MyD88-dependent suppression of NF-B sig-
nalling to hinder production of proinﬂammatory cytokines
and type-1 interferons. In addition to such inhibitory effect
of microﬁlarae over DCs, these also results partial inhibi-
tion of the function of human Langerhans cells (LCs) and
prevent proliferation of CD4+ T cells.74 Interestingly, TLR2
and TLR4 have been reported to be expressed on circulating
B cells during helminthic infection that uphold and main-
tain Th2 type-immune responses to make “worm favourable”
conditions.75 These specialized B cell subsets are known as
regulatory B cells (Breg) and their immunosuppressive func-
tion is also regulated through TLR4.75 TLR4 on these cells
trigger induction of IL-10 secretion from B cell through Myd88-
dependent pathway.76 Particularly in ﬁlariasis, Breg cells are
responsible for the induction as well as maintenance of hypo-
responsive immune status with elevated levels of Treg, IL-10
and ﬁlarial-speciﬁc IgG4.75 This Breg mediated responses
is recompensing as patients remain asymptomatic due to
devoid of excessive immunopathology.75 However, this typ-
ical Th2 environment by Breg results secondary infections
by bacteria and/or fungi due to lack of protective immune
cells repertoires in ﬁlarial subjects.75 A probable mechanism
of TLR activation by ﬁlarial parasites has been shown in
Fig. 5. 1 6;2  0(2):193–204
Conclusion  and  future  prospects
Studies on the recognition of infectious pathogens through
TLRs have signiﬁcantly contributed to our understanding
of the underlying mechanisms of innate immune defense
against the deadliest parasites. In this review, we  have
put forward the ﬁndings made on the role played by two
crucial members of the TLR family viz. TLR2 and TLR4
against the most threatening infectious diseases. We have
discussed different previously reported ﬁndings on types of
pathogenic ligand alongside the mechanism of action of
inﬂammatory cascade originated from TLR4 and TLR2 in
tuberculosis, malaria, leishmaniasis, ﬁlariasis, and trypanoso-
miasis. Interesting outcomes achieved in the experimental
vaccine adjuvants and/or immunotherapy against active
leishmaniasis promises for effective future applications as
well as opens new possibilities regarding the use of TLR based
immunotherapeutic control strategies for malaria or other dis-
eases. Similarly, immunomodulatory TLR4 ligand from ﬁlarial
parasites has also shown to control allergic reaction by inhib-
iting proinﬂammatory mediators and this strategy could be
used effectively to combat inﬂammatory pathology of malaria
or other disease to reduce mortality. Similarly, TLR4 has been
emerged as a target of therapeutics for immunopharmacolog-
ical control of infectious and/or inﬂammatory diseases.77
However, many  questions remain to be answered for this
aspect. Thus more  concluding information rather inferences
are need to be gathered through population based studies.
Similarly, there is a need to search for other microbial ligands
for a same microbe/parasite as well as interplay between the
TLRs and obviously the signalling crosstalk. From immuno-
logical perspectives, study of mechanism of parasite/microbe
induced polarization of major antigen presenting cells may
offer us new target for developing therapeutic strategy to
restore Th1 (to eliminate infection) or Th2 biased (to protect
host from overt inﬂammation) immune response.
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